Long-acting parenteral drug delivery systems for the treatment of chronic diseases
The management of chronic conditions often requires patients to take daily medication for an
extended duration. However, the need for daily dosing can lead to nonadherence to the …
extended duration. However, the need for daily dosing can lead to nonadherence to the …
Lipid nanoparticles functionalized with antibodies for anticancer drug therapy
AC Marques, PC Costa, S Velho, MH Amaral - Pharmaceutics, 2023 - mdpi.com
Nanotechnology takes the lead in providing new therapeutic options for cancer patients. In
the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs) …
the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs) …
Biomaterial‐based gene therapy
Y Yu, Y Gao, L He, B Fang, W Ge, P Yang, Y Ju… - MedComm, 2023 - Wiley Online Library
Gene therapy, a medical approach that involves the correction or replacement of defective
and abnormal genes, plays an essential role in the treatment of complex and refractory …
and abnormal genes, plays an essential role in the treatment of complex and refractory …
In vitro prostate cancer treatment via CRISPR‐Cas9 gene editing facilitated by polyethyleneimine‐derived graphene quantum dots
B Lee, K Gries, AR Valimukhametova… - Advanced Functional …, 2023 - Wiley Online Library
Abstract CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)‐Cas9
(CRISPR associated protein 9) is a programmable gene editing tool with a promising …
(CRISPR associated protein 9) is a programmable gene editing tool with a promising …
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
P Huang, H Deng, C Wang, Y Zhou… - Advanced …, 2024 - Wiley Online Library
Messenger RNA (mRNA)‐based therapy has emerged as a powerful, safe, and rapidly
scalable therapeutic approach that involves technologies for both mRNA itself and the …
scalable therapeutic approach that involves technologies for both mRNA itself and the …
[HTML][HTML] Targeted drug delivery systems for elemene in cancer therapy: The story thus far
H Tian, F Zhao, Q Qi, B Yue, B Zhai - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Elemene (ELE) is a group of broad-spectrum anticancer active ingredients with low toxicity
extracted from traditional Chinese medicines (TCMs), such as Curcumae Rhizoma and …
extracted from traditional Chinese medicines (TCMs), such as Curcumae Rhizoma and …
Delivery of RNAs to specific organs by lipid nanoparticles for gene therapy
K Godbout, JP Tremblay - Pharmaceutics, 2022 - mdpi.com
Gene therapy holds great promise in the treatment of genetic diseases. It is now possible to
make DNA modifications using the CRISPR system. However, a major problem remains: the …
make DNA modifications using the CRISPR system. However, a major problem remains: the …
Recent advances in nanoparticle-mediated co-delivery system: A promising strategy in medical and Agricultural Field
M Li, X Sun, M Yin, J Shen, S Yan - International Journal of Molecular …, 2023 - mdpi.com
Drug and gene delivery systems mediated by nanoparticles have been widely studied for life
science in the past decade. The application of nano-delivery systems can dramatically …
science in the past decade. The application of nano-delivery systems can dramatically …
[HTML][HTML] Microfluidic platforms in diagnostic of ovarian cancer
FD Moghaddam, D Dadgar, Y Esmaeili… - Environmental …, 2023 - Elsevier
The most important reason for death from ovarian cancer is the late diagnosis of this
disease. The standard treatment of ovarian cancer includes surgery and chemotherapy …
disease. The standard treatment of ovarian cancer includes surgery and chemotherapy …
Selective organ targeting nanoparticles: from design to clinical translation
J Li, H Wang - Nanoscale Horizons, 2023 - pubs.rsc.org
Targeting nanoparticle is a very promising therapeutic approach that can precisely target
specific sites to treat diseases. Research on nanoscale drug delivery systems has made …
specific sites to treat diseases. Research on nanoscale drug delivery systems has made …